Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy-Reference-Cited by-同舟云学术

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy

Published:2013-02-12 Issue:1 Volume:32 Page:31-38
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Bedke Jens,Gouttefangeas Cécile,Singh-Jasuja Harpreet,Stevanović Stefan,Behnes Carl-Ludwig,Stenzl Arnulf

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-013-1033-3/fulltext.html

Reference57 articles.

1. Lokich J (1997) Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 20:416–418

2. Dengjel J et al (2006) Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Clin Cancer Res 12:4163–4170

3. Saenz-Lopez P et al (2010) Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue. Tissue Antigens 75:110–118

4. Attig S et al (2009) Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Cancer Res 69:8412–8419

5. Schendel DJ et al (1993) Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol 151:4209–4220

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvante Therapie beim Nierenzellkarzinom;Uro-News;2022-09

2. Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future;Cancers;2022-03-09

3. Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review;Croatian Medical Journal;2020-08

4. Seguridad de nivolumab en pacientes con carcinoma de células renales metastásico: experiencia española en urología en la práctica clínica real;Actas Urológicas Españolas;2019-09

5. Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting;Actas Urológicas Españolas (English Edition);2019-09